1 |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA, 2016, 315(8): 801-810.
|
2 |
RUDD K E, JOHNSON S C, AGESA K M, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219): 200-211. doi:10.1016/s0140-6736(19)32989-7
doi: 10.1016/s0140-6736(19)32989-7
|
3 |
MACHADO F R, CAVALCANTI A B, BOZZA F A, et al. The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study [J]. Lancet Infect Dis, 2017, 17(11): 1180-1189.
|
4 |
XIE J, WANG H, KANG Y, et al. The Epidemiology of Sepsis in Chinese ICUs: A National Cross-Sectional Survey[J]. Crit Care Med, 2020, 48(3): 209-218. doi:10.1097/ccm.0000000000004155
doi: 10.1097/ccm.0000000000004155
|
5 |
中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等. 中国脓毒症早期预防与阻断急诊专家共识[J]. 中华急诊医学杂志, 2020, 29(7): 885-895. doi:10.3760/cma.j.issn.1671-0282.2020.07.001
doi: 10.3760/cma.j.issn.1671-0282.2020.07.001
|
6 |
DARDEN D B, KELLY L S, FENNER B P, et al. Dysregulated Immunity and Immunotherapy after Sepsis [J]. J Clin Med, 2021, 10(8): 1742. doi:10.3390/jcm10081742
doi: 10.3390/jcm10081742
|
7 |
陆元兰, 岑祥莹, 张炉英, 等. 血小板早期变化与脓毒症所致器官功能障碍相关性[J]. 实用医学杂志, 2020, 36(4): 493-497. doi:10.3969/j.issn.1006-5725.2020.04.015
doi: 10.3969/j.issn.1006-5725.2020.04.015
|
8 |
卞兵兵, 李慧慧. 脓毒症患者早期血小板相对减少对临床结局的影响[J]. 中国急救医学, 2022, 42(7): 561-566. doi:10.3969/j.issn.1002-1949.2022.07.002
doi: 10.3969/j.issn.1002-1949.2022.07.002
|
9 |
常晨阳, 胡绍雯, 邓国平, 等. 中性粒细胞计数与淋巴细胞和血小板计数比值在儿童脓毒症预后中的预测价值[J]. 实用医学杂志, 2023, 39(22): 2958-2963. doi:10.3969/j.issn.1006-5725.2023.22.017
doi: 10.3969/j.issn.1006-5725.2023.22.017
|
10 |
MORRELL C N, PARISER D N, HILT Z T, et al. The Platelet Napoleon Complex-Small Cells, but Big Immune Regulatory Functions[J]. Annu Rev Immunol, 2019, 37(4): 125-144. doi:10.1146/annurev-immunol-042718-041607
doi: 10.1146/annurev-immunol-042718-041607
|
11 |
QIU X, LI J, BONENFANT J, et al. Dynamic changes in human single-cell transcriptional signatures during fatal sepsis[J]. J Leukoc Biol, 2021, 110(6): 1253-1268. doi:10.1002/jlb.5ma0721-825r
doi: 10.1002/jlb.5ma0721-825r
|
12 |
ZHANG J Y, WANG X M, XING X, et al. Single-cell landscape of immunological responses in patients with COVID-19[J]. Nat Immunol, 2020, 21(9): 1107-1118. doi:10.1038/s41590-020-0762-x
doi: 10.1038/s41590-020-0762-x
|
13 |
T/CRHA 022-2023. 脓毒症诊断与治疗规范 [S]. 中国研究型医院学会, 2023-8-30.
|
14 |
EVANS L, RHODES A, ALHAZZANI W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47(11):1181-1247.
|
15 |
GAUER R, FORBES D, BOYER N. Sepsis: Diagnosis and Management[J]. Am Fam Physician, 2020, 101(7): 409-418.
|
16 |
BASODAN N, MEHMADI A E AL, MEHMADI A E AL, et al. Septic Shock: Management and Outcomes[J]. Cureus, 2022, 14(12): e32158.
|
17 |
MILLER T, EMAMIAN N, GLICK Z, et al. Association between resuscitation in the critical care resuscitation unit and in-hospital mortality[J]. Am J Emerg Med, 2022, 60(10): 96-100. doi:10.1016/j.ajem.2022.07.042
doi: 10.1016/j.ajem.2022.07.042
|
18 |
WEINBERGER J, KLOMPAS M, RHEE C. What Is the Utility of Measuring Lactate Levels in Patients with Sepsis and Septic Shock?[J]. Semin Respir Crit Care Med, 2021, 42(5): 650-661. doi:10.1055/s-0041-1733915
doi: 10.1055/s-0041-1733915
|
19 |
PUGA M L, MENEGUETI M G, SILVESTRINI M M A, et al. Performance of microvesicles as biomarkers of clinical outcome in sepsis and trauma: A pilot study[J]. Biomed Pharmacother, 2022, 146(12): 1-11. doi:10.1016/j.biopha.2021.112490
doi: 10.1016/j.biopha.2021.112490
|
20 |
MARTINS C N, SPANHOFER A K, WIENER S, et al. Uptake of platelets by cancer cells and recycling of the platelet protein CD42a[J]. J Thromb Haemost, 2022, 20(1): 170-181. doi:10.1111/jth.15543
doi: 10.1111/jth.15543
|
21 |
WANG Z, XU Y, SUN Y, et al. Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia[J]. Front Pediatr, 2023, 10(1): 1-7. doi:10.3389/fped.2022.1062900
doi: 10.3389/fped.2022.1062900
|
22 |
KELLER C D, SPAGNOL F, ALEGRETTI A P, et al. Flow cytometry immunophenotyping of healthy platelets and hospitalized patients with suspected platelet dysfunction: Challenges for establishing a cutoff value[J]. Hematol Transfus Cell Ther, 2023, 23(8): S2531-1379.
|
23 |
RUEDA J A A, ACOSTA J, RABINOVICH O, et al. Evaluation of survival and functionality in frozen platelets[J]. Hematol Transfus Cell Ther, 2023, (1): 25. doi:10.1016/j.htct.2023.01.002
doi: 10.1016/j.htct.2023.01.002
|
24 |
GALLUZZI L, VITALE I, AARONSON S A, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018[J]. Cell Death Differ, 2018, 25(3): 486-541.
|
25 |
MADDUX A B, HILLER T D, OVERDIER K H, et al. Innate immune function and organ failure recovery in adults with sepsis[J]. J Intensive Care Med, 2019, 34(6): 486-494. doi:10.1177/0885066617701903
doi: 10.1177/0885066617701903
|
26 |
BOE D M, CURTIS B J, CHEN M M, et al. Extracellular traps and macrophages: new roles for the versatile phagocyte[J]. J Leukoc Biol, 2015, 97(6): 1023-1035. doi:10.1189/jlb.4ri1014-521r
doi: 10.1189/jlb.4ri1014-521r
|
27 |
DENNING N L, AZIZ M, GURIEN S D, et al. DAMPs and NETs in sepsis[J]. Front Immunol, 2019, 10(10): 2536. doi:10.3389/fimmu.2019.02536
doi: 10.3389/fimmu.2019.02536
|
28 |
ALHAMDI Y, ABRAMS S T, CHENG Z, et al. Circulating histones are major mediators of cardiac injury in patients with sepsis[J]. Crit Care Med, 2015, 43(10): 2094-2103. doi:10.1097/ccm.0000000000001162
doi: 10.1097/ccm.0000000000001162
|
29 |
COLON D F, WANDERLEY C W, FRANCHIN M, et al. Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis[J]. Crit Care, 2019, 23(1): 113. doi:10.1186/s13054-019-2407-8
doi: 10.1186/s13054-019-2407-8
|